MedPath

Wolff-Parkinson-White Syndrome Anterograde Refractory Period of Accessory Duct

Not Applicable
Terminated
Conditions
Wolff-Parkinson-White Syndrome
Interventions
Procedure: esophagal stimulation
Registration Number
NCT00873470
Lead Sponsor
Nantes University Hospital
Brief Summary

The study consists of the realization of a new esophageal stimulation for patients already stimulated 10 years ago.

The investigators would like to make a long term evaluation of the evolution of anterograde effective refractory period of accessory duct in the WPW syndrome.

This study will be realized by esophageal stimulation.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
13
Inclusion Criteria
  • 21 < age < 64 years
  • First esophagal stimulation with evaluation of effective anterograde refractory period > 10 years
  • Informed consent signed
  • Diagnosis of Wolff-Parkinson-White syndrome
  • No procedure of ablation of accessory duct
Exclusion Criteria
  • Ablation of accessory duct
  • Patient with contraindication to esophageal stimulation
  • Patient with contraindication to effort test

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Stimulationesophagal stimulationAll patients included have the stimulation
Primary Outcome Measures
NameTimeMethod
Measurement of effective anterograde refractory period of accessory duct and its evolution for a follow up superior to 10 yearsDay 0
Secondary Outcome Measures
NameTimeMethod
Triggering a supra-ventricular tachycardia during the stimulation.Day 0
Presence of symptoms linked to WPW syndrome during the interval separating the 2 esophageal stimulation.Day 0

Trial Locations

Locations (1)

Nantes UH

🇫🇷

Nantes, France

© Copyright 2025. All Rights Reserved by MedPath